Cargando…
Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma
Autores principales: | Giudice, Valentina, Pezzullo, Luca, Ciancia, Giuseppe, D’Addona, Matteo, D’Alto, Francesca, Gorrese, Marisa, Cuffa, Bianca, Selleri, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083938/ https://www.ncbi.nlm.nih.gov/pubmed/35615322 http://dx.doi.org/10.4084/MJHID.2022.042 |
Ejemplares similares
-
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review
por: D’Addona, Matteo, et al.
Publicado: (2022) -
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia
por: Giudice, Valentina, et al.
Publicado: (2022) -
A case series of blastic plasmacytoid dendritic cell neoplasia
por: Serio, B, et al.
Publicado: (2020) -
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery
por: D’Addona, Matteo, et al.
Publicado: (2023) -
P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE
por: Pezzullo, Luca, et al.
Publicado: (2023)